Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomaglumetad methionil safety interaction with methamphetamine
NCT03106571Phase 1Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pomaglumetad methionil in methamphetamine use disorder (MUD) (4 arms), sponsored by University of California, Los Angeles. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Aug 2017; status: terminated.
02
Drugs
pomaglumetad methionil
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT03106571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106571.